← FDA Drug Approvals (Drugs@FDA)
MESALAMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2004-09-17
Drug application
- FDA Application #
ANDA076751- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MESALAMINE
- Generic name
- MESALAMINE
- Active ingredients
- MESALAMINE
- Dosage form
- ENEMA
- Route
- RECTAL
- Marketing status
- Prescription
- Sponsor
- PADAGIS ISRAEL
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- First approval
- 2004-09-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown